ReviewGeroScience2026
Histone modifications in biological age determination: mechanisms, biomarkers, and therapeutic perspectives.
Review in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Restoring glucose metabolic homeostasis to attenuate ovarian aging: mechanisms and clinical prospects.Journal of ovarian research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Aging is the progressive decline in function at the cellular, tissue, and organismal levels that ultimately leads to mortality. The longevity of an organism is influenced by various internal and external factors, including nutrition, exercise, metabolic dysfunction, genomic instability, and epigenetic imbalance. Histone modifications, such as acetylation, methylation, phosphorylation, and ubiquitination, play a critical role in aging. These modifications illustrate histone changes crucial for regulating chromatin architecture and gene expression. The epigenetic clock signifies the impact of aging on our cells and is essential for accurately determining biological age. It demonstrates significant associations with histone modifications, underscoring their mechanistic importance in age-related changes. Histone alterations are closely associated with age-related diseases such as cancer, neurological disorders, and cardiovascular conditions. While the mechanistic function of histone modifications in biological aging is well-established, clinical application remains constrained. Emerging clinical studies targeting histone-modifying enzymes are beginning to investigate their potential as therapeutic options for age-related disorders. This review seeks to provide a comprehensive examination of histone modifications, including acetylation, methylation, and phosphorylation, as well as the impact of histone alterations on biological age, age-related diseases, and the importance of the epigenetic clock, with the aim of enhancing understanding of the epigenetic mechanisms associated with aging and facilitating the development of therapies to promote healthy aging. In this review, we also focus on the current status of such clinical trials and discuss future directions for translating these epigenetic insights into clinical applications.
Indexed as
Identifiers
41642447What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.